Calculating Your Business Case For Pharmaceutical Continuous Manufacturing

By Richard Steiner, senior manager, business strategy, Pharmatech Associates

Development and commercialization of a drug product in a highly regulated market involves a significant amount of risk. Advanced manufacturing processes such as pharmaceutical continuous manufacturing (PCM) introduces additional risk to the drug life cycle and is often a barrier to implementing any new technology.

Review key considerations as a Pharmatech Associates expert introduces a useful financial equation to calculate amortization to develop the business case for PCM and provides a few real-world cases. Discover how PCM can support specific business needs and how to implement it.